Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bridging Study of L059(Levetiracetam) in Patients With Epilepsy by Double Blind Method

NCT00600509 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00600509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00600509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bridging Study of L059(Levetiracetam) in Patients With Epilepsy by Double Blind Method
Lead sponsor
UCB Pharma
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2001
Completion date
July 31, 2003
Enrollment
216 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy